Below the Biologically Effective Dose
- PMID: 30782307
- PMCID: PMC6384515
- DOI: 10.3238/arztebl.2019.0009c
Below the Biologically Effective Dose
Comment in
-
In Reply.Dtsch Arztebl Int. 2019 Jan 7;116(1-2):10. doi: 10.3238/arztebl.2019.0010. Dtsch Arztebl Int. 2019. PMID: 30782308 Free PMC article. No abstract available.
Comment on
-
The Screening, Diagnosis, Treatment, and Follow-Up of Breast Cancer.Dtsch Arztebl Int. 2018 May 4;115(18):316-323. doi: 10.3238/arztebl.2018.0316. Dtsch Arztebl Int. 2018. PMID: 29807560 Free PMC article.
Similar articles
-
Capsule Commentary on Tosteson et al., Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium.J Gen Intern Med. 2016 Apr;31(4):411. doi: 10.1007/s11606-016-3594-5. J Gen Intern Med. 2016. PMID: 26857730 Free PMC article. No abstract available.
-
Screening for breast cancer.Ann Intern Med. 2010 Nov 2;153(9):618-9; author reply 619. doi: 10.7326/0003-4819-153-9-201011020-00016. Ann Intern Med. 2010. PMID: 21041585 No abstract available.
-
Radiation Dose in Breast Imaging.Radiol Technol. 2018 Mar;89(4):371M-390M. Radiol Technol. 2018. PMID: 29691360 Review.
-
Screening is only part of the answer to breast cancer.Ann Intern Med. 2014 Jun 17;160(12):861-3. doi: 10.7326/M14-0616. Ann Intern Med. 2014. PMID: 24711098 No abstract available.
-
Current estimate of costs of lung cancer screening in the United States.Thorac Surg Clin. 2015 May;25(2):205-15. doi: 10.1016/j.thorsurg.2014.12.005. Epub 2015 Mar 7. Thorac Surg Clin. 2015. PMID: 25901564 Review.
References
-
- Haviland JS, Owen JR, Dewar JA, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow up results of two randomised trials. Lancet Oncol. 2013;14:1086–1094. - PubMed
-
- Owen JR, Ashton A, Bliss JM, et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long term results of a randomised trial. Lancet Oncol. 2006;7:467–471. - PubMed
-
- Haviland JS, Bentzen SM, Bliss JM, Yarnold JR. Prolongation of overall treatment time as a cause of treatment failure in early breast cancer: an analysis of the UK START (Standardisation of Breast Radiotheraoy) trials of radiotherapy fractionation. Radiother Oncol. 2016;121:420–423. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical